Phone: (504) 865-5741
421 Lindy Boggs Building
Department of Chemical and Biomolecular Engineering
New Orleans, LA 70118-5674
Heterogeneous catalysis: Sol-gel synthesis, catalytic oxidation, supported metal catalysts, clay chemistry, nuclear waste disposal, heavy metal removal from salt water, controlled drug release, chemotherapy.
My recent research interest over the last five years has been centered in the area of controlled drug release. In particular, we are exploring the possibility of encapsulating drugs which are targeted to control neurological disorders such as epilepsy and Parkinson’s. These devices are implanted and strategically located in areas of the brain such as the temporal lobe (epilepsy abatement), or substantia nigra (Parkinson’s). They can also be used as a follow up to the surgical removal of malignant tumors. Implantation of these devices in areas in which they are most needed eliminates passage through the brain blood barrier (BBB). More importantly the drug dose, which is usually administered by systemic administration (pills or injections) can be significantly reduced. This approach can minimize damage to critical organs throughout the drug trajectory. This approach, which has been used successfully, in both model laboratory animals and in the case of chemotherapy, on humans, has shown promising results. These studies are carried out jointly between Tulane University, the Institute of Neurology and Neurosurgery in Mexico City and the National Metropolitan University of Mexico.
B.Ch.E., Rensselaer Polytechnic Institute, 1961
M.A., The Johns Hopkins University, 1963
Ph.D., The Johns Hopkins University, 1965
Approximately 200 publications
300 Lindy Boggs Center, Tulane University, New Orleans, LA 70118, T: 504-314-2914, F: 504-865-6744 email@example.com